Literature DB >> 16845245

Cholestasis secondary to hyperthyroidism made worse by methimazole.

Mohammed Majeed1, Ambika Babu.   

Abstract

A 28-year-old man presented with weight loss, jaundice, and pruritus. This was diagnosed to be secondary to Graves disease and the patient was prescribed methimazole. He returned 2 weeks later with worsening of his jaundice. Further investigation, including liver biopsy, indicated that there was superimposed methimazole-induced cholestasis. Discontinuation of methimazole and treatment of hyperthyroidism with lithium followed by radioactive iodine therapy resulted in resolution of his symptoms. This case highlights the fact that worsening cholestasis after therapy for Graves disease should raise the possibility of thionamide-induced exaggeration of liver cholestasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845245     DOI: 10.1097/00000441-200607000-00012

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

1.  Steroids for the treatment of methimazole-induced severe cholestatic jaundice in a 74-year-old woman with type 2 diabetes.

Authors:  Mei Zhang; Hongwen Zhou; Ronghua He; Fusong Di; Liu Yang; Tao Yang
Journal:  Endocrine       Date:  2010-01-05       Impact factor: 3.633

2.  A case of severe cholestatic jaundice with hyperthyroidism successfully treated with methimazole.

Authors:  Hitoshi Ichikawa; Hirotoshi Ebinuma; Shinichirou Tada; Keisuke Ojiro; Yoshiyuki Yamagishi; Nobuhiro Tsukada; Emi Hongou; Osamu Funae; Rie Irie; Hidetsugu Saito; Toshifumi Hibi
Journal:  Clin J Gastroenterol       Date:  2009-06-17

3.  Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot: case report.

Authors:  Chuan Shen; Cai-Yan Zhao; Fang Liu; Ya-Dong Wang; Jun Yu
Journal:  BMC Gastroenterol       Date:  2010-08-14       Impact factor: 3.067

4.  Atypical clinical manifestations of graves' disease: an analysis in depth.

Authors:  Mohamed Osama Hegazi; Sherif Ahmed
Journal:  J Thyroid Res       Date:  2011-11-01

Review 5.  Liver failure due to antithyroid drugs: report of a case and literature review.

Authors:  Sarantis Livadas; Xenofon Xyrafis; Frangiskos Economou; Georgios Boutzios; Maria Christou; Aristea Zerva; Athanasios Karachalios; Helen Palioura; Sotiria Palimeri; Evanthia Diamanti-Kandarakis
Journal:  Endocrine       Date:  2010-05-18       Impact factor: 3.925

Review 6.  Challenges in early identification of causes and treatment of cholestasis in patients with hyperthyroidism: a case report and literature review.

Authors:  Baimei Zeng; Ling Yuan; Jun Chu; Yanqing Yang; Shide Lin
Journal:  J Int Med Res       Date:  2019-12-16       Impact factor: 1.671

7.  Cholestatic Hepatitis in Graves' Disease: A Diagnostic Challenge.

Authors:  Metri Haddaden; Angy Hanna; Fadi Odish; Samir Husami; Zaid Imam; Mamon Tahhan
Journal:  ACG Case Rep J       Date:  2021-01-14

8.  Clinical spectrum and therapeutic approach to hepatocellular injury in patients with hyperthyroidism.

Authors:  Daniel Ferraz de Campos Mazo; Graciana Bandeira Salgado de Vasconcelos; Maria Adelaide Albergaria Pereira; Evandro Sobroza de Mello; Telesforo Bacchella; Flair Jose Carrilho; Eduardo Luiz Rachid Cançado
Journal:  Clin Exp Gastroenterol       Date:  2013-02-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.